Condition: Venous Leg Ulcer · Leg Injuries and Disorders · Sponsor: SolasCure Limited
This is an adaptive open-label, first-in-human (Phase IIa) study designed to assess the safety (and efficacy) of Aurase Wound Gel, an enzymatic debridement product, intended for topical application to sloughy venous leg ulcers (VLU)
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Center for Clinical Research | San Francisco, California, United States | — |
| Mayo Clinic Jacksonville | Jacksonville, Florida, United States | — |
| Doctors Research Network | Miami, Florida, United States | — |
| University of Miami | Miami, Florida, United States | — |
| FASMA | Salem, Virginia, United States | — |
| Óbudai Egészségügyi Centrum Kft. | Budapest, Hungary | — |
| Uno Medical Trials | Budapest, Hungary | — |
| Hull Royal Infirmary | Hull, United Kingdom | — |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04956900